Levosimendan, or (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono- ]propanedinitrile, which has been mentioned for the treatment of congestive heart failure, is useful in the treatment of septic shock.